Investment Summary

EGS Healthcare Capital Partners Invests In Ardais

On March 19, 2003, private equity firm EGS Healthcare Capital Partners invested in life science company Ardais for 34M USD

Investment Highlights
  • This is EGS Healthcare Capital Partners’ 1st transaction in the Life Science sector.
  • This is EGS Healthcare Capital Partners’ largest (disclosed) transaction.
  • This is EGS Healthcare Capital Partners’ 2nd transaction in the United States.
  • This is EGS Healthcare Capital Partners’ 1st transaction in Massachusetts.

Investment Summary
Date 2003-03-19
Target Ardais
Sector Life Science
Investor(s) EGS Healthcare Capital Partners
Deal Type Venture
Deal Value 34M USD

Target

Ardais

Lexington, Massachusetts, United States
Ardais Corporation is a privately held clinical genomics company that sources and sells human disease tissue and associated management software for drug discovery applications.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

EGS Healthcare Capital Partners

Rowayton, Connecticut, United States
Category Private Equity Firm
Founded 1999
PE ASSETS 135M USD
Size Small
Type Sector Focused
DESCRIPTION

EGS Healthcare Capital Partners is a specialist private equity firm focused on investments in the healthcare sector. Specific areas of interest include biotechnology, specialty pharmaceutical, and medical device companies. EGS typically invests in late-stage private and emerging public companies with promising products. EGS prefers to lead investments with an initial commitment of $5 million per transaction. The Firm generally seeks board representation. EGS Healthcare Partner was formed in 1999 and is based in Rowayton, Connecticut.

DEAL STATS #
Overall 2 of 7
Sector (Life Science) 1 of 3
Type (Venture) 2 of 5
State (Massachusetts) 1 of 3
Country (United States) 2 of 6
Year (2003) 1 of 2
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2002-09-02 CytoLogix

Cambridge, Massachusetts, United States

CytoLogix Corporation is a privately held device company that has patented and developed systems for the automation of slide-based pathology tissue staining.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2003-03-25 Endius

Plainville, Massachusetts, United States

Endius, Inc. is a privately held medical device company that had developed and commercialized a minimally invasive access system for spine surgery.

Buy -
Mergr

Product

Company

Legal